TickerFacts.

Regen BioPharma Inc (RGBP): Cash & Equivalents

Annual figures by period end, from SEC filings.

$69.6K
As of 2025-09-30
$239
As of 2026-06-30
+10.7%
3-year compound annual growth
$727.2K2013-09-30: $115.9K2016-09-30: $24.8K2017-09-30: $270.0K2018-09-30: $8.0K2019-09-30: $7.9K2020-09-30: $02021-09-30: $727.2K2022-09-30: $51.2K2023-09-30: $121.0K2024-09-30: $7162025-09-30: $69.6K$69.6K
2013-09-30 Cash & Equivalents (USD) 2025-09-30
Period endedCash & EquivalentsChange YoYSource filing
2025-09-30$69.6Kn/m2025-12-30, Balance as of period end
2024-09-30$716-99.4%2025-12-30, Balance as of period end
2023-09-30$121.0K+136.4%2025-05-13, Balance as of period end
2022-09-30$51.2K-93.0%2022-11-15, Balance as of period end
2021-09-30$727.2Kn/a2022-11-15, Balance as of period end
2020-09-30$0-100.0%2021-08-04, Balance as of period end
2019-09-30$7.9K-2.0%2021-08-04, Balance as of period end
2018-09-30$8.0K-97.0%2021-06-21, Balance as of period end
2017-09-30$270.0K+987.6%2018-12-27, Balance as of period end
2016-09-30$24.8Kn/a2018-01-05, Balance as of period end
No annual figure between 2013-09-30 and 2016-09-30.
2013-09-30$115.9Kn/a2014-12-18, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Regen BioPharma Inc (RGBP)2025-09-30$69.6Kn/m
Clene Inc. (CLNN)2025-12-31$5.19M-57.3%
Abvc Biopharma, Inc. (ABVC)2025-12-31$681.5K+174.4%
Vyome Holdings, Inc (HIND)2025-12-31$4.98Mn/m
Allarity Therapeutics, Inc. (ALLR)2025-12-31$14.69M-24.8%
Lisata Therapeutics, Inc. (LSTA)2025-12-31$15.96M-1.6%
Provectus Biopharmaceuticals, Inc. (PVCT)2025-12-31$251.3K-18.3%
Can-Fite BioPharma Ltd. (CANF)2025-12-31$5.53M+14.6%
Medicinova Inc (MNOV)2025-12-31$30.81M-23.7%

Compare RGBP, CLNN, ABVC, HIND side by side · Screen every company in Pharmaceutical Preparations ↗